The online version of this article (doi:10.1186/1824-7288-40-70) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
CR and ZAA conceived the design of the study. EV and SL participated in the design of the study, performed the data collection. MPD and CC participated in coordination of the study and drafted the manuscript and the statistical analysis. SAR helped to draft the manuscript. All authors read and approved the final manuscript.
Early discharge of mother/neonate dyad has become a common practice, and its effects are measured by readmission rates. We evaluated the safety of early discharge followed by an individualized Follow-up programme and the efficacy in promoting breastfeeding initiation and duration.
During a nine-month period early discharge followed by an early targeted Follow-up was carried out in term neonates in the absence of weight loss <10% or hyperbilirubinaemia at risk of treatment. Follow-up visits were performed at different timepoints with a specific flow-chart according to both bilirubin levels and weight loss at discharge.
During the study period early discharge was performed in 419 neonates and Follow-up was carried out in 408 neonates (97.4%). No neonates required readmission for hyperbilirubinaemia and dehydration during the first 28 days of life. Breastfeeding rate was 90.6%, 75.2%, 41.5% at 30, 90 and 180 days of life, respectively. A six-month phone interview was performed for 383 neonates (93.8%) and satisfaction of parents about early discharge was high in 345 cases (90.1%).
Early discharge in association with an individualized Follow-up programme resulted safe for the neonate and effective for breastfeeding initation and duration.
American Academy of Pediatrics and American College of Obstetrics and Gynecology: Guidelines for Perinatal Care. 1992, Elk Grove Village, IL: American Academy of Pediatrics; Washington, DC: American College of Obstetricians and Gynecologists, 91-116. Postpartum and follow-up care, 3, 4
Braveman P, Egerter S, Pearl M, Marchi K, Miller C: Problems associated with early discharge of newborn infants. Early discharge of newborns and mothers: a critical review of the literature. Pediatrics. 1995, 96: 716-726. PubMed
Oddie SJ, Craven V, Deakin K, Westman J, Scally A: Severe neonatal hypernatraemia: a population based study. Arch Dis Child Fatal Neonatal Ed. 2013, 98: F384-F387. 10.1136/archdischild-2012-302908. CrossRef
American Academy of Pediatrics. Committee on Fetus and Newborn: Hospital stay for healthy term newborns. Pediatrics. 1995, 96: 788-790.
Yonemoto N, Dowswell T, Nagai S, Mori R: Schedules for home visits in the early postpartum period. Cochrane Database Syst Rev. 2013, 23: 7-
American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004, 114: 297-316. CrossRef
Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK, Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group: Predischarge screening for severe neonatal hyperbilirubinaemia identifies infants who need phototherapy. J Pediatr. 2013, 162: 477-482. 10.1016/j.jpeds.2012.08.022. CrossRefPubMed
De Luca D, Carnielli VP, Paollilo P: Neonatal hyperbilirubinemia and early discharge from maternity ward. Eur J Pediatr. 2009, 68: 1025-1030. CrossRef
American Academy of Pediatrics. Committee on Fetus and Newborn: Policy statement-Hospital stay for healthy term newborns. Pediatrics. 2010, 125: 405-409. CrossRef
Romagnoli C, Tiberi E, Barone G, Curtis MD, Regoli D, Paolillo P, Picone S, Anania S, Finocchi M, Cardiello V, Giordano L, Paolucci V, Zecca E: Development and validation of serum bilirubin nomogram to predict the absence of risk for severe hyperbilirubinaemia before discharge: a prospective, multicenter study. Ital J Pediatr. 2012, 1: 38-46.
Bhutani VK, Maisels MJ, Stark AR, Buonocore G, Expert Committee for Severe Neonatal Hyperbilirubinemia; European Society for Pediatric Research; American Academy of Pediatrics: Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants ≥ 35 weeks of gestation. Neoanatology. 2008, 94: 63-67. 10.1159/000113463. CrossRef
Martín-Iglesias S, Del-Cura-González I, Sanz-Cuesta T, Arana-Cañedo Argüelles C, Rumayor-Zarzuelo M, Alvarez-de la Riva M, Lloret-Sáez Bravo AM, Férnandez-Arroyo RM, Aréjula-Torres JL, Aguado-Arroyo Ó, Góngora-Maldonado F, García-Corraliza M, Sandoval-Encinas N, Tomico-delRío M, Cornejo-Gutiérrez AM: Effectiveness of an implementation strategy for a breastfeeding guideline in Primary Care: cluster randomised trial. BMC Fam Pract. 2011, 12: 144-10.1186/1471-2296-12-144. PubMedCentralCrossRefPubMed
Newman TB, Liljestrand P, Escobar GJ: Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005, 159: 113-119. PubMed
- Individualized follow up programme and early discharge in term neonates
Maria Pia De Carolis
Serena Antonia Rubortone
Antonio Alberto Zuppa
- BioMed Central
Neu im Fachgebiet Pädiatrie
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II